Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 11, 2026
Why Is AeroVironment, Inc. (AVAV) Stock Down -6% Today?

Why Is AeroVironment, Inc. (AVAV) Stock Down -6% Today?

Key Takeaways

  • AVAV shares are declining approximately 6% in Monday's session, trading near $158.19, compared to Friday's close of $168.29
  • Continued selling pressure stems from lingering overhang tied to a significant Q3 FY2026 earnings and revenue miss reported in March 2026, compounded by a full-year guidance cut
  • The termination of AeroVironment's approximately $1.4 billion SCAR Space Force contract — which was reopened for competitive bidding in early 2026 — remains a structural headwind for the stock
  • A Pomerantz Law Firm investor investigation announced in the wake of the guidance cut adds legal overhang and amplifies institutional caution
  • Defense sector sentiment has turned more cautious amid shifting government spending priorities and Pentagon budget scrutiny in 2026
  • Traders are watching for Q4 FY2026 earnings, expected in late June or early July 2026, which management has framed as a potential record quarter

Opening Summary

AeroVironment, Inc. (AVAV) is a Huntsville, Alabama-based defense technology company specializing in small unmanned aircraft systems (UAS), loitering munitions, and precision strike solutions, as well as space, cyber, and directed energy products. The company serves the U.S. military and international defense customers, with its Switchblade loitering munitions and Puma UAS among its most recognized platforms. AVAV shares are declining approximately 6% in Monday's session, trading near $158.19 against a Friday close of $168.29, as a combination of unresolved fundamental concerns, contract uncertainty, and a cautious defense sector backdrop weigh on investor sentiment.

Q3 FY2026 Earnings Miss and Guidance Cut

The primary fundamental driver pressing AVAV lower over recent sessions has been the company's Q3 FY2026 results, released on March 10, 2026, which significantly missed expectations. Revenue came in at $408.1 million, well short of the analyst consensus of approximately $487.9 million — a miss of roughly 16%. Non-GAAP EPS of $0.64 missed the consensus estimate of $0.72 by $0.08. More impactful than the quarterly miss was management's decision to cut full-year FY2026 guidance, reducing the revenue outlook to $1.85–$1.95 billion (from $1.9–$2.0 billion) and non-GAAP EPS guidance to $2.75–$3.10 against a prior Street consensus of $3.28–$3.31. Management attributed the shortfall to timing of revenue recognition and funding delays in its Space, Cyber, and Directed Energy (SCDE) segment. The stock fell sharply on the news and has remained under pressure, with the May 11 session extending those losses.

SCAR Contract Termination Removes a Pillar of the Thesis

A significant structural concern for AVAV has been the loss of its SCAR (Space and Cyberspace Advanced Reconnaissance) Space Force contract, valued at approximately $1.4 billion and representing a core part of the SCDE segment's revenue pipeline. Earlier in 2026, the Pentagon announced it would reopen the program to competitive bidding rather than maintain sole-source status with AeroVironment. Raymond James responded by issuing a rare triple downgrade on AVAV, cutting its rating from Strong Buy to Underperform in a single action. The potential loss of this contract, which had underpinned bullish forecasts for the SCDE division, remains unresolved and continues to create uncertainty around the company's long-term revenue base.

Legal Overhang and Broader Sentiment Headwinds

Investor class-action interest has added a further layer of caution around AVAV. Following the Q3 guidance reduction, Pomerantz LLP announced an investigation into whether the company or its officers engaged in securities fraud or other unlawful conduct. While no formal lawsuit has been filed, this type of legal overhang has historically amplified institutional selling and increases short-term volatility. At the same time, the broader defense sector has faced scrutiny in 2026 as Pentagon budget discussions and DOGE-related government spending reviews have raised questions about the durability of near-term DoD procurement contracts for smaller, specialized defense technology firms.

Market Context and Trading Activity

Monday's session volume for AVAV is running below the 90-day average of approximately 1.5 million shares per day, suggesting the move reflects repositioning rather than a high-conviction surge of new selling. The broader Nasdaq has been trading with moderate positive momentum entering the week, meaning AVAV's decline is diverging from index performance and remains stock-specific. From a technical perspective, the stock has fallen approximately 60% from its 52-week high of around $417, with support levels in the $155–$160 range now being tested. A decisive break below this zone could invite additional selling pressure, while a stabilization here may attract value-oriented buyers ahead of the Q4 earnings release.

Trending AI Robots

For traders watching volatile defense and technology stocks like AVAV, Tickeron's Trending AI Robots page offers a curated look at the platform's best-performing automated trading strategies under current market conditions. Tickeron runs hundreds of AI-powered bots spanning thousands of tickers, each built with distinct strategies, timeframes, performance metrics, and traded symbols — but only those delivering the strongest real-time results appear in the Trending section. Whether you trade momentum, mean reversion, or sector-specific setups, the Trending AI Robots page provides a data-driven filter for identifying systematic strategies aligned with today's market dynamics.

What Comes Next for AVAV

The most anticipated near-term catalyst for AVAV is the Q4 FY2026 earnings report, expected in late June or early July 2026, covering the fiscal quarter ending April 30, 2026. Management guided for a record Q4, with significantly higher revenue and margins compared to the prior quarter, citing strong backlog visibility and anticipated recognition of delayed SCDE revenues. The company reported a book-to-bill ratio of 1.60x as of Q3, with total funded backlog of $1.1 billion and unfunded backlog of $3.0 billion — figures that support the bull case if execution improves. Key risks include further funding delays within the DoD, adverse outcomes on the SCAR competitive rebid, continued margin compression in the Autonomous Systems division, and unresolved legal developments. Analyst price targets as of the most recent updates range from $200 to $390, reflecting wide dispersion in how the Street is pricing execution risk versus the company's long-term UAS and directed-energy growth runway.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: AVAV

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for AVAV turns positive, indicating new upward trend

AVAV saw its Momentum Indicator move above the 0 level on September 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 72 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AVAV just turned positive on September 14, 2026. Looking at past instances where AVAV's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.

AVAV moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +7.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAV advanced for three days, in 246 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The 10-day RSI Indicator for AVAV moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 28 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for AVAV crossed bearishly below the 50-day moving average on August 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

AVAV broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AVAV entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. AVAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.849) is normal, around the industry mean (6.438). P/E Ratio (149.026) is within average values for comparable stocks, (59.605). Projected Growth (PEG Ratio) (1.565) is also within normal values, averaging (2.578). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.893) is also within normal values, averaging (18.155).

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.8B. The market cap for tickers in the group ranges from 4.49 to 2.01T. SPCX holds the highest valuation in this group at 2.01T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -1%. For the same Industry, the average monthly price growth was -14%, and the average quarterly price growth was -7%. ELMT experienced the highest price growth at 42%, while VWAV experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 199%. For the same stocks of the Industry, the average monthly volume growth was 173% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 69
Price Growth Rating: 66
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
AVAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of unmanned aircraft and charging systems

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
241 18th Street South
Phone
+1 703 418-2828
Employees
4091
Web
https://www.avinc.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.